These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 29383863

  • 1. Effectiveness of modified hyper-CVAD chemotherapy regimen in the treatment of adult acute lymphoblastic leukemia: a retrospective experience.
    Jalaeikhoo H, Rajaeinejad M, Keyhani M, Zokaasadi M, Dehghani Firoozabadi MM.
    Cancer Med; 2018 Mar; 7(3):594-599. PubMed ID: 29383863
    [Abstract] [Full Text] [Related]

  • 2. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA, Cabanillas ME, Konopleva M, Thomas DA, Pierce SA, Escalante CP, Kantarjian HM, O'Brien SM.
    Cancer; 2004 Mar 15; 100(6):1179-85. PubMed ID: 15022284
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA, O'Brien S, Thomas DA, Pierce SA, Lam TP, Kantarjian HM.
    Cancer; 2002 Jan 15; 94(2):285-91. PubMed ID: 11900213
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison between Hyper-CVAD and PETHEMA ALL-93 in Adult Acute Lymphoblastic Leukemia: A Single-Center Study.
    Erkut N, Akidan O, Selim Batur D, Karabacak V, Sonmez M.
    Chemotherapy; 2018 Jan 15; 63(4):207-213. PubMed ID: 30304722
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen.
    Thomas D, O'Brien S, Faderl S, Ravandi F, Jabbour E, Pierce S, Cortes J, Kantarjian H.
    Cancer; 2010 Oct 01; 116(19):4580-9. PubMed ID: 20572037
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of Hyper-CVAD/MA and CHALL-01 regimens in the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia patients under 60 years old].
    Huang AJ, Wang LB, Du J, Tang GS, Cheng H, Gong SL, Gao L, Qiu HY, Ni X, Chen J, Chen L, Zhang WP, Wang JM, Yang JM, Hu XX.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Aug 14; 40(8):625-632. PubMed ID: 31495127
    [Abstract] [Full Text] [Related]

  • 11. Feasibility and outcome of the hyper-CVAD regimen in patients with adult acute lymphoblastic leukemia.
    Portugal RD, Loureiro MM, Garnica M, Pulcheri W, Nucci M.
    Clin Lymphoma Myeloma Leuk; 2015 Jan 14; 15(1):52-7. PubMed ID: 25037887
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Liu L, Jiao W, Zhang Y, Qu Q, Li X, Wu D.
    Leuk Res; 2015 Mar 14; 39(3):323-8. PubMed ID: 25638269
    [Abstract] [Full Text] [Related]

  • 13. A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.
    Kim SY, Park JH, Yoon SY, Cho YH, Lee MH.
    Cancer Chemother Pharmacol; 2018 Feb 14; 81(2):393-398. PubMed ID: 29294168
    [Abstract] [Full Text] [Related]

  • 14. Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
    Guzauskas GF, Villa KF, Vanhove GF, Fisher VL, Veenstra DL.
    J Adolesc Young Adult Oncol; 2017 Mar 14; 6(1):53-61. PubMed ID: 27779442
    [Abstract] [Full Text] [Related]

  • 15. Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
    Rytting ME, Jabbour EJ, Jorgensen JL, Ravandi F, Franklin AR, Kadia TM, Pemmaraju N, Daver NG, Ferrajoli A, Garcia-Manero G, Konopleva MY, Borthakur G, Garris R, Wang S, Pierce S, Schroeder K, Kornblau SM, Thomas DA, Cortes JE, O'Brien SM, Kantarjian HM.
    Am J Hematol; 2016 Aug 14; 91(8):819-23. PubMed ID: 27178680
    [Abstract] [Full Text] [Related]

  • 16. Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial.
    Jabbour E, Richard-Carpentier G, Sasaki Y, Konopleva M, Patel K, Roberts K, Gu Z, Wang F, Huang X, Sasaki K, Short NJ, Jain N, Ravandi F, Daver NG, Kadia TM, Alvarado Y, DiNardo CD, Issa GC, Pemmaraju N, Garcia-Manero G, Verstovsek S, Wang S, Khoury JD, Jorgensen J, Champlin R, Khouri I, Kebriaei P, Schroeder H, Khouri M, Mullighan CG, Takahashi K, O'Brien SM, Kantarjian H.
    Lancet Haematol; 2020 Jul 14; 7(7):e523-e533. PubMed ID: 32589978
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the Hyper-CVAD with an institutional regimen for the treatment of acute lymphoblastic leukemia in adults in a hospital of Mexico].
    Ramos-Peñafiel CO, Cabrera-García Á, Rozen-Fuller E, González-León G, Balderas C, Kassack-Ipiña JJ, Castellanos-Sinco H, Martínez-Murillo C, Montaño-Figueroa E, Martínez-Tovar A, Olarte-Carrillo I, Santoyo-Sánchez A, Collazo-Jaloma J.
    Rev Peru Med Exp Salud Publica; 2014 Jul 14; 31(3):525-9. PubMed ID: 25418653
    [Abstract] [Full Text] [Related]

  • 18. Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy.
    Garg R, Kantarjian H, Thomas D, Faderl S, Ravandi F, Lovshe D, Pierce S, O'Brien S.
    Cancer; 2009 May 15; 115(10):2147-54. PubMed ID: 19298009
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Two Pediatric-Inspired Regimens to Hyper-CVAD in Hispanic Adolescents and Young Adults With Acute Lymphoblastic Leukemia.
    Almanza-Huante E, Espinosa-Bautista K, Rangel-Patiño J, Demichelis-Gómez R.
    Clin Lymphoma Myeloma Leuk; 2021 Jan 15; 21(1):55-62.e2. PubMed ID: 32893130
    [Abstract] [Full Text] [Related]

  • 20. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ.
    J Clin Oncol; 2000 Feb 15; 18(3):547-61. PubMed ID: 10653870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.